Author: healthadmin
New research published in journal personality and individual differences found that narcissism and perfectionism are more closely related in everyday life than previously thought, and that moment-to-moment changes in these traits shape the way people think and feel. Previous research has demonstrated that narcissism and perfectionism are linked as stable personality traits. Narcissism typically includes two different forms: grandiose narcissism, which is characterized by self-confidence and a sense of superiority, and vulnerable narcissism, which is characterized by insecurity and sensitivity to criticism. Perfectionism can similarly be divided into two dimensions. One is perfectionistic striving to set and pursue high standards,…
WASHINGTON — Labor, lawmakers and environmental advocates gathered this week to voice opposition to proposed federal rules that would roll back protections for people living near hazardous facilities across the country. “This is just the latest example of this administration going to great lengths to prioritize industry profits over the health and safety of workers, first responders, and the communities that allow businesses to survive in the first place,” Democratic Rep. Paul Tonko of New York said at a press conference on March 25 at the Capitol in Washington, D.C. The event was sponsored by the Chemical Hazard Prevention Coalition,…
For some evangelical Christians, attributing mental illness to demonic forces makes sense, while for others it creates harmful barriers to medical care. Recent qualitative research published in Spirituality in clinical practice We outline how these widespread psychological explanations act as a double-edged sword for individuals experiencing psychological distress. This study shows that integrating religious beliefs with standard mental health care may be a safer path for many faith communities. Religion often determines how people interpret their physical and mental health. Psychologists recognize that religious frameworks provide a primary system for individuals to understand the world around them. By relying on…
Imagine a future where all 70 million Americans enrolled in Medicare have access to a personal AI assistant that helps them navigate the health care system with clarity and confidence. Instead of sorting through plan documents or deciphering unfamiliar policy terms, beneficiaries receive personalized guidance to help them understand their options and choose the coverage that best fits their needs. That future may not be far away, according to recent comments from Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz, MD. In fact, CMS recently issued a request for information on how AI can be used to improve…
The University of Maryland Marlene Stewart Greenbaum Comprehensive Cancer Center (UMGCCC) has been awarded a prestigious $3 million National Cancer Institute (NCI) Career Development Award to develop the next generation of oncology researchers focused on treating patients from all backgrounds. The Advancing Oncologic Research Communities in Health Equity (ARCH) K12 program supports junior faculty and postdoctoral fellows in the final stages of their training who are interested in pursuing research to improve cancer outcomes for patients from a wide range of backgrounds within the community. “This award recognizes UMGCCC’s excellence in community-informed cancer research and treatment tailored to the patients…
Dr. Donald Cohn has been developing gene therapies for rare immune diseases in children for more than 30 years. This week, his role in clinical trials culminated in the first-ever U.S. Food and Drug Administration-approved treatment for severe leukocyte adhesion deficiency-I, a genetic disease characterized by recurrent infections and often early death. This rare childhood disease affects approximately 1 in 1 million children worldwide. Mutations in the ITGB2 gene disrupt the normal function of CD11 and CD18, two proteins that work together to help white blood cells reach and respond to infections. When this process is disrupted, children are susceptible…
Damon Runyon scientists and industry partners gathered on Tuesday, March 24, in Cambridge, Massachusetts, for the 2026 Cancer Care Advancement Research Symposium hosted by Amgen. Accelerated Cancer Cures (ACC) is a multi-million dollar collaborative project aimed at supporting a new generation of clinical researchers who translate the latest scientific discoveries into new diagnostics and treatments for patients. Founded in 2011 and led by the Damon Runyon Cancer Research Foundation, the initiative includes scientists from the nation’s top universities and research institutions, as well as participants from AbbVie, Amgen, ARIAD, Celgene, Eli Lilly and Company, Genentech, Gilead, Merck, Novartis, Pfizer, and…
Listen to the audio version of this article (generated by AI).Given strong scientific evidence that glyphosate, the world’s most widely used herbicide, can cause cancer and other health problems, U.S. and European regulators should take urgent steps to more tightly regulate glyphosate, an international group of scientists said Friday. Scientists gathered at the Glyphosate Symposium in Seattle on March 25-26 to examine a variety of studies conducted over the past decade and determined that the evidence that glyphosate herbicides can harm human health is “now too strong to justify further delays in regulating glyphosate.” The group confirmed previous findings related…
Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries using these techniques have focused only on one small region of one organ or tissue. At the University of Chicago’s Pritzker School of Molecular Engineering (UChicago PME), Assoc. Professor Nicolas Chevrier’s group has developed a new system for understanding how disease affects molecules, cells, tissues, and organs throughout the body. This is a major goal of both scientists and doctors. This interdisciplinary research was led by Maggie Clevenger, a staff scientist in the lab, and included several industry and academic collaborators.…
A team led by Dr. Kuan-lin Huang has been selected as the recipient of the Alzheimer’s Disease Data Initiative’s $1 million Alzheimer’s Insight AI Award, announced on March 20. Dr. Huang is an associate professor of genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai. The award recognizes the development of Biomni-AD, an advanced AI-powered “collaborative scientist” designed to significantly reduce the time needed to generate scientific insights from complex biomedical data. The Mount Sinai team worked with partners at Stanford University on the winning project. Originally conceived as a single $1 million prize, the contest…